CoChat

The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)

Chérin, P., Rose, C., de Roux‐Serratrice, C., Tardy, D., Dobbelaere, D., Grosbois, B., Hachulla, E., Jaussaud, R., Javier, R.‐M., Noël, E., Clerson, P., Hartmann, A. · 2010 · Journal of Inherited Metabolic Disease
Cited by 78

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: Gaucher disease (GD), the most prevalent inherited lysosomal storage disorder, is caused by deficient glucocerebrosidase activity. Type 1 GD (GD1), the most common variant, is classically considered non‐neuronopathic. Methods: We performed a national cross‐sectional observational survey—the French Observatoire on Gaucher Disease (FROG)—in patients with GD1 between March 2005 and September 2006. The study included all patients over 18 years of age with confirmed GD1 who attended participating centers for regular follow‐up. Results: One hundred and five patients were included, in whom we studied the prevalence and characteristics of relevant neurological symptoms associated with the neuraxis. Of these, 51 (49%) GD1 patients presented at least one neurological symptom. Four patients (4%) had Parkinson disease and 22 (21%) presented with at least one parkinsonian sign or at least one sign frequently associated with Parkinson disease. Five patients (5%) had a previous diagnosis of peripheral neuropathy. Other central nervous system symptoms were recorded in 20 (19%) patients and other peripheral nervous system symptoms in 39 (37%) patients. Conclusions: These data challenge the current classification of GD, and suggest that the three forms of GD each involve a different profile of neurological manifestations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10545-010-9095-5

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews

    Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597 · cited 1×

    “Conversely, glucocerebrosidase gene mutations have recently emerged as a potential risk factor for idiopathic PD (Aharon-Peretz et al. 2004; Bembi et al. 2003; Clark et al. 2005; Gan-Or et al. 2008; Machaczka et al. 1999; McKeran et al. 1985; Tayebi et al. 2003; Ziegler et al. 2007).”
    Background

Show all 1 references

Cited by

See all 78

Metadata

Authors
Chérin, P., Rose, C., de Roux‐Serratrice, C., Tardy, D., Dobbelaere, D., Grosbois, B., Hachulla, E., Jaussaud, R., Javier, R. ‐., Noël, E., Clerson, P., & Hartmann, A.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2010-06-02
Volume
33
Issue
4
Pages
331-338
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2038612623
Cited by
78
References
1
FWCI
4.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). https://app.cochat.ai/papers/10.1007/s10545-010-9095-5
The paper
Chérin, P., Rose, C., de Roux‐Serratrice, C., Tardy, D., Dobbelaere, D., Grosbois, B., Hachulla, E., Jaussaud, R., Javier, R. ‐., Noël, E., Clerson, P., & Hartmann, A. (2010). The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-010-9095-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.